Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
173.30
+0.73 (0.42%)
At close: Mar 6, 2026, 4:00 PM EST
174.49
+1.19 (0.69%)
After-hours: Mar 6, 2026, 5:57 PM EST
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.82 billion as of March 6, 2026. Its market cap has increased by 274.04% in one year.
Market Cap
6.82B
Enterprise Value
6.54B
1-Year Change
274.04%
Ranking
Category
Stock Price
$173.30
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.82B, an increase of 4,615.73%. That is a compound annual growth rate of 171.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.82B | 13.61% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 8.38B |
| Axsome Therapeutics | 8.30B |
| Halozyme Therapeutics | 7.95B |
| Nuvalent | 7.82B |
| Cytokinetics | 7.44B |
| Krystal Biotech | 7.42B |
| Kymera Therapeutics | 6.82B |
| Arcellx | 6.69B |